EBITDA of Aspen Pharmacare Holdings 2017-2022
In 2022, earnings before interest, tax, depreciation and amortization (EBITDA) of Aspen Pharmacare Holdings amounted to approximately 11.01 billion South African rand (around 630 million U.S. dollars), marking an increase in comparison to the previous year. Based in South Africa, Aspen Pharmacare is the largest pharmaceutical company in Africa.